PDS Biotechnology (PDSB) Tops Q1 EPS by 11c
Tweet
Share
E-mailGet Alerts PDSB Hot Sheet
Join SI Premium – FREE
PDS Biotechnology (NASDAQ: PDSB) reported Q1 EPS of ($0.21), $0.11 better than the analyst estimate of ($0.32).
For earnings history and earnings-related data on PDS Biotechnology (PDSB) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- H&R Block (HRB) Tops Q4 EPS by 7c, Offers Guidance
- Immunome, Inc. (IMNM) Reports Q2 Loss of $0.65
- Aardvark Therapeutics (AARD) Tops Q2 EPS by 21c
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
